Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia [NA]

View source ↗

Summary

This clinical trial evaluates the efficacy and safety of ATNC-MDD V1, a transcranial magnetic stimulation (TMS) with cognitive training, for mild Alzheimer's de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATNC-MDD V1

Snippet

Sponsor: Advanced Technology & Communications | Conditions: Alzheimer's Disease, Dementia | NA | Status: RECRUITING